0001477932-24-002262.txt : 20240419 0001477932-24-002262.hdr.sgml : 20240419 20240419170021 ACCESSION NUMBER: 0001477932-24-002262 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240417 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cosmos Health Inc. CENTRAL INDEX KEY: 0001474167 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 270611758 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41308 FILM NUMBER: 24858672 BUSINESS ADDRESS: STREET 1: 5 AGIOU GEORGIOU, PILEA CITY: THESSALONIKI STATE: J3 ZIP: 55438 BUSINESS PHONE: 312-536-3102 MAIL ADDRESS: STREET 1: 5 AGIOU GEORGIOU, PILEA CITY: THESSALONIKI STATE: J3 ZIP: 55438 FORMER COMPANY: FORMER CONFORMED NAME: Cosmos Holdings Inc. DATE OF NAME CHANGE: 20140106 FORMER COMPANY: FORMER CONFORMED NAME: PRIME ESTATES & DEVELOPMENTS INC DATE OF NAME CHANGE: 20091008 8-K 1 cosm_8k.htm FORM 8-K cosm_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 17, 2024 

 

Cosmos Health Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-54436 

 

27-0611758 

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

5 AGIOU GEORGIOU, PILEA, THESSALONIKI, Greece

 

55438

(Address of principal executive offices) 

 

(Zip Code)

 

Registrant’s telephone number, including area code (312) 865-0026

 

N/A

(Former name or former address, if changed since last report.)

 

Title of Each Class

 

Trading Symbol

 

Name of Each Exchange On Which Registered

Common Stock, $.001 par value

 

COSM

 

Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

ITEM 3.01 NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING 

 

On April 19, 2024, Cosmos Health Inc. (the “Company”) announced that, on April 17, 2024, it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2023 (the “Form 10-K”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq letter has no immediate effect on the listing of the Company’s shares.  As a non-compliant company, an indicator reflecting the Company’s non-compliance will be broadcast over Nasdaq’s market data dissemination network and will also be made available to third party market data providers.

 

Nasdaq’s notification letter states that the Company has 60 calendar days to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. If Nasdaq accepts the Company’s plan, then Nasdaq may grant the Company up to 180 days from the prescribed due date for filing the Form 10-K to regain compliance. If Nasdaq does not accept the Company’s plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.

 

The Company intends to resolve the deficiency and regain compliance with the Nasdaq Listing Rules.  

 

A press release announcing the matters described above and titled “Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K” is attached hereto as Exhibit 99.1 and incorporated herein by reference. Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d) Exhibits 

 

Number

 

 

 

 

 

99.1

 

Press Release dated April 19, 2024 titled “Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K”.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 
2

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

COSMOS HEALTH INC.

 

 

 

 

Date: April 19, 2024

By:

/s/ Georgios Terzis

Georgios Terzis

 

Chief Financial Officer

 

 

 
3

 

 EX-99.1 2 cosm_ex991.htm PRESS RELEASE cosm_ex991.htm

EXHIBIT 99.1

 

Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K

 

CHICAGO, IL / ACCESSWIRE / April 19, 2024 / Cosmos Health Inc. (“Cosmos Health” or the “Company’’) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that, on April 17, 2024, it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2023 (the “Form 10-K”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.

 

The Nasdaq letter has no immediate effect on the listing of the Company’s shares. As a non-compliant company, an indicator reflecting the Company’s non-compliance will be broadcast over Nasdaq’s market data dissemination network and will also be made available to third party market data providers.

 

Nasdaq’s notification letter states that the Company has 60 calendar days to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. If Nasdaq accepts the Company’s plan, then Nasdaq may grant the Company up to 180 days from the prescribed due date for filing the Form 10-K to regain compliance. If Nasdaq does not accept the Company’s plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.

 

The Company intends to resolve the deficiency and regain compliance with the Nasdaq Listing Rules.

 

Greg Siokas, Chief Executive Officer of Cosmos Health, stated: “Our team is diligently working towards regaining compliance with the Nasdaq Listing Rules. We expect to achieve compliance in short order.”

 

About Cosmos Health Inc.

Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe® and C-Sept®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency, it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com,  www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.

 

Forward-Looking Statements

With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may” and “could”, are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company’s ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic and the war in Ukraine, on the Company’s business, operations and the economy in general, and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations Contact:

BDG Communications

cosm@bdgcommunications.com

+44 207 0971 653

 EX-101.SCH 3 cosm-20240417.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 cosm-20240417_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Entity Address Country EX-101.CAL 5 cosm-20240417_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 cosm-20240417_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 cosm-20240417_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
Apr. 17, 2024
Cover [Abstract]  
Entity Registrant Name Cosmos Health Inc.
Entity Central Index Key 0001474167
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Apr. 17, 2024
Entity File Number 000-54436
Entity Incorporation State Country Code NV
Entity Tax Identification Number 27-0611758
Entity Address Address Line 1 5 AGIOU GEORGIOU
Entity Address Address Line 2 PILEA
Entity Address City Or Town THESSALONIKI
Entity Address Postal Zip Code 55438
City Area Code 312
Local Phone Number 865-0026
Security 12b Title Common Stock, $.001 par value
Trading Symbol COSM
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Address Country GR
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://cosm.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cosm-20240417.xsd cosm-20240417_cal.xml cosm-20240417_def.xml cosm-20240417_lab.xml cosm-20240417_pre.xml cosm_8k.htm http://xbrl.sec.gov/dei/2023 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cosm_8k.htm": { "nsprefix": "cosm", "nsuri": "http://cosm.com/20240417", "dts": { "schema": { "local": [ "cosm-20240417.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "cosm-20240417_cal.xml" ] }, "definitionLink": { "local": [ "cosm-20240417_def.xml" ] }, "labelLink": { "local": [ "cosm-20240417_lab.xml" ] }, "presentationLink": { "local": [ "cosm-20240417_pre.xml" ] }, "inline": { "local": [ "cosm_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://cosm.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-04-17to2024-04-17", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "cosm_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-04-17to2024-04-17", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "cosm_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://cosm.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001477932-24-002262-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-24-002262-xbrl.zip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cosm_8k_htm.xml IDEA: XBRL DOCUMENT 0001474167 2024-04-17 2024-04-17 iso4217:USD shares iso4217:USD shares 0001474167 false 8-K 2024-04-17 Cosmos Health Inc. NV 000-54436 27-0611758 5 AGIOU GEORGIOU PILEA THESSALONIKI GR 55438 312 865-0026 Common Stock, $.001 par value COSM NASDAQ false false false false false